Knowledge Center

Patent / Sep 30, 2021

Compositions for use in treating meibomian gland dysfunction

Authors:

Carla Vozone
Mohammad Salman
George Magrath
Courtney Smith

Source:

WO 2021191273

The invention provides methods, compositions, and kits containing a minocycline topical suspension, for treating meibomian gland dysfunction and related disorders.

Also in the Knowledge Center

/ Jan 01, 1989

Rhodium-containing hydrogenation catalysts for the conversion of methacycline to doxycycline

Scientific Article

View

/ Jan 01, 1989

Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline

Scientific Article

View

/ Jan 01, 1989

Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same

Scientific Article

View

Browser not supported

Knowledge Center

Compositions for use in treating meibomian gland dysfunction

Also in the Knowledge Center

Rhodium-containing hydrogenation catalysts for the conversion of methacycline to doxycycline

Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline

Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same

Related Content

Capabilities

Filling

API